AIkido Pharma Inc (AIKI)

[mannken]

You bring up a valid point

But I do not put much credence in insider purchases, or lack thereof.

Why, because a CEO may have options or performance compensation when milestones are reached that far exceed any benefits from insider purchases.

There are many stocks that move up without insider purchases and many that move down with insider purchases.

To your point though, insider purchases are a vote of confidence, a PR mechanism of some sort to the retail world, seeing a CEO put up his own money is helpful, but CEO's are not always right and can mis-calculate the larger forces of market sentiment.

IMO, Spex should only be played for parabolic moves for a couple of reasons. One, patent litigation has recently been unfavorable in the courts. Two, as you alluded to 'paying law firms', is probably the long term business model of Spex, shelf offerings all the time to pay for litigation costs.

To comment on the float being in tight hands, I wouldn't put any credence into that either, a large portion of the float is naked right now.

To close out my comments and opinions, if the 1.00 area can hold for a bottom, there will probably a parabolic move in the next few weeks to align with the (2) recent shelf offerings, so they can sell at a better price, the CEO knows it and it's all precision market planning.

Good luck to all !